Standard Dosing: Microdosing is often better tolerated than full-dose GLP-1 therapy
Two protocols dominate the research community
CrossRef Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 20102023 Jialin Wu, Bonan Chen, Fuda Xie, Jiahui Hu, Mingyu Liang, Yang Lyu, Peiyao Yu, Tiejun Feng, Muyang Huang, Canbin Fang, Ka Fai To, Terry Cheuk-Fung Yip, Xingxin Wang, Wei Kang Hepatology International .2026;[Epub] CrossRef Development and Validation of a Deep Learningenabled Single Breath-hold Abbreviated MRI Protocol for Hepatocellular Carcinoma Diagnosis Yunfei Zhang, Zhijun Geng, Xianling Qian, Yuyao Xiao, Ruofan Sheng, Mengsu Zeng Radiology: Artificial Intelligence .2026;[Epub] CrossRef Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (20202025) Qi-Feng Chen, Song Chen, Xiongying Jiang, Jiongliang Wang, Ming Zhao Liver Cancer .2026
Without pharmacokinetic data, the claim that these patches deliver a therapeutic dose is scientifically unverifiable
Zhang Q, Chibalina MV, Bengtsson M et al (2014) Na+ current properties in islet alpha- and beta-cells reflect cell-specific Scn3a and Scn9a expression
Third-Party Testing Independent laboratory analysis of a product by a company with no financial interest in the results